PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma
Zihan Zhou,1,2 Dianbin Mu,3 Dexian Zhang,3 Xianbin Zhang,2 Xingchen Ding,2 Jia Yang,2 Xinbin Bai,4 Man Hu2 1Department of Oncology, Weifang Medical University, Weifang, Shandong, People’s Republic of China; 2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-12-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/pd-l1-in-combination-with-cd8til-and-hif-1alpha-are-promising-prognosi-peer-reviewed-article-CMAR |
| _version_ | 1818641205182857216 |
|---|---|
| author | Zhou Z Mu D Zhang D Zhang X Ding X Yang J Bai X Hu M |
| author_facet | Zhou Z Mu D Zhang D Zhang X Ding X Yang J Bai X Hu M |
| author_sort | Zhou Z |
| collection | DOAJ |
| description | Zihan Zhou,1,2 Dianbin Mu,3 Dexian Zhang,3 Xianbin Zhang,2 Xingchen Ding,2 Jia Yang,2 Xinbin Bai,4 Man Hu2 1Department of Oncology, Weifang Medical University, Weifang, Shandong, People’s Republic of China; 2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China; 3Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China; 4Department of Oncology, Jining Cancer Hospital, Jining, Shandong, People’s Republic of ChinaCorrespondence: Man HuDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jiyan Road 440, Jinan 250117, Shandong, People’s Republic of ChinaTel +86-531-67626152Fax +86-531-67626153Email human5770@163.comObjective: The aim of this study was to evaluate the prognosis effect of PD-L1 in combination with CD8+ tumor-infiltrating lymphocyte (TIL) or HIF-1α in head and neck squamous cell carcinoma (HNSCC).Methods: A total of 63 patients who underwent surgical resection were included in this study. The level of PD-L1, CD8+ TIL, and HIF-1α was determined by immunohistochemical analysis. The survival of patients was evaluated by Kaplan–Meier analysis. The prognostic power of these parameters was evaluated by C-index.Results: We observed that the survival of patients, who had a high level of PD-L1 in tumor cells, was significantly shorter than those who had a low level of PD-L1. However, the survival of patients who had a high level of PD-L1 in tumor microenvironment was significantly longer than patients with a low level of PD-L1 in tumor microenvironment. In addition, high level of CD8+ tumor-infiltrating lymphocyte or low level of HIF-1α level suggests a better prognosis. Moreover, we observed that PD-L1 in combination with CD8+ tumor-infiltrating lymphocyte and HIF-1α could significantly improve the prognostic effect of current TNM stage.Conclusion: The results of this study suggest that the level of PD-L1, CD8+TIL, and HIF-1α are useful prognostic biomarkers for patients with HNSCC. Incorporating these biomarkers into current TNM stage of HNSCC improve the discriminatory capability of TNM stage.Keywords: PD-L1, HIF-1α, CD8+TIL, HNSCC, prognosis |
| first_indexed | 2024-12-16T23:23:28Z |
| format | Article |
| id | doaj.art-d9eb836f4a6f4d64bb56d8437d33dccd |
| institution | Directory Open Access Journal |
| issn | 1179-1322 |
| language | English |
| last_indexed | 2024-12-16T23:23:28Z |
| publishDate | 2020-12-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Cancer Management and Research |
| spelling | doaj.art-d9eb836f4a6f4d64bb56d8437d33dccd2022-12-21T22:12:07ZengDove Medical PressCancer Management and Research1179-13222020-12-01Volume 12132331323960602PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell CarcinomaZhou ZMu DZhang DZhang XDing XYang JBai XHu MZihan Zhou,1,2 Dianbin Mu,3 Dexian Zhang,3 Xianbin Zhang,2 Xingchen Ding,2 Jia Yang,2 Xinbin Bai,4 Man Hu2 1Department of Oncology, Weifang Medical University, Weifang, Shandong, People’s Republic of China; 2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China; 3Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China; 4Department of Oncology, Jining Cancer Hospital, Jining, Shandong, People’s Republic of ChinaCorrespondence: Man HuDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jiyan Road 440, Jinan 250117, Shandong, People’s Republic of ChinaTel +86-531-67626152Fax +86-531-67626153Email human5770@163.comObjective: The aim of this study was to evaluate the prognosis effect of PD-L1 in combination with CD8+ tumor-infiltrating lymphocyte (TIL) or HIF-1α in head and neck squamous cell carcinoma (HNSCC).Methods: A total of 63 patients who underwent surgical resection were included in this study. The level of PD-L1, CD8+ TIL, and HIF-1α was determined by immunohistochemical analysis. The survival of patients was evaluated by Kaplan–Meier analysis. The prognostic power of these parameters was evaluated by C-index.Results: We observed that the survival of patients, who had a high level of PD-L1 in tumor cells, was significantly shorter than those who had a low level of PD-L1. However, the survival of patients who had a high level of PD-L1 in tumor microenvironment was significantly longer than patients with a low level of PD-L1 in tumor microenvironment. In addition, high level of CD8+ tumor-infiltrating lymphocyte or low level of HIF-1α level suggests a better prognosis. Moreover, we observed that PD-L1 in combination with CD8+ tumor-infiltrating lymphocyte and HIF-1α could significantly improve the prognostic effect of current TNM stage.Conclusion: The results of this study suggest that the level of PD-L1, CD8+TIL, and HIF-1α are useful prognostic biomarkers for patients with HNSCC. Incorporating these biomarkers into current TNM stage of HNSCC improve the discriminatory capability of TNM stage.Keywords: PD-L1, HIF-1α, CD8+TIL, HNSCC, prognosishttps://www.dovepress.com/pd-l1-in-combination-with-cd8til-and-hif-1alpha-are-promising-prognosi-peer-reviewed-article-CMARpd-l1hif-1αcd8+tilhnsccprognosis |
| spellingShingle | Zhou Z Mu D Zhang D Zhang X Ding X Yang J Bai X Hu M PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma Cancer Management and Research pd-l1 hif-1α cd8+til hnscc prognosis |
| title | PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma |
| title_full | PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma |
| title_fullStr | PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma |
| title_full_unstemmed | PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma |
| title_short | PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma |
| title_sort | pd l1 in combination with cd8 til and hif 1 alpha are promising prognosis predictors of head and neck squamous cell carcinoma |
| topic | pd-l1 hif-1α cd8+til hnscc prognosis |
| url | https://www.dovepress.com/pd-l1-in-combination-with-cd8til-and-hif-1alpha-are-promising-prognosi-peer-reviewed-article-CMAR |
| work_keys_str_mv | AT zhouz pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma AT mud pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma AT zhangd pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma AT zhangx pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma AT dingx pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma AT yangj pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma AT baix pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma AT hum pdl1incombinationwithcd8tilandhif1alphaarepromisingprognosispredictorsofheadandnecksquamouscellcarcinoma |